Foreign-invested pharmaceutical firms increase market share

With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.

According to Mirae Asset Securities, the domestic ethical market for outpatients in March accounted for 571.4 billion won, showing a 9.7 -percent increase over the same period of last year and reflecting t...